Literature DB >> 11407481

Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes.

I Lambert1, M Debiec-Rychter, P Guelinckx, A Hagemeijer, R Sciot.   

Abstract

Acral myxoinflammatory fibroblastic sarcoma is a rare tumor of the distal extremities. We present the hitherto unreported karyotypic abnormalities of this new entity. The tumor presented as a mass in the dorsum of the foot in a 53-year-old woman and showed the typical virocyte-like and lipoblast-like cells in a myxoid and inflammatory background. Cytogenetic analysis revealed a complex karyotype with a reciprocal translocation t(1;10) (p22;q24) in addition to the loss of chromosomes 3 and 13. Fluorescence in situ hybridization with the 769E11YAC and BAC 31L5 and 2H23 probes showed the breakpoint to be located proximally to BCL10 and distally to GOT1 genes on chromosomes 1p22 and 10q24, respectively. The presence of these clonal chromosomal changes supports the neoplastic nature of acral myxoinflammatory fibroblastic sarcoma and underscores that it represents a separate entity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407481     DOI: 10.1007/s004280000376

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

Review 1.  Myxoinflammatory fibroblastic sarcoma: investigations by comparative genomic hybridization of two cases and review of the literature.

Authors:  Daniel Baumhoer; Kathrin Glatz; Hans-Jürgen Schulten; László Füzesi; Renato Fricker; Christoph Kettelhack; Paula Hasenboehler; Martin Oberholzer; Gernot Jundt
Journal:  Virchows Arch       Date:  2007-08-11       Impact factor: 4.064

2.  Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.

Authors:  William B Laskin; John F Fetsch; Markku Miettinen
Journal:  Am J Surg Pathol       Date:  2014-01       Impact factor: 6.394

3.  Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.

Authors:  Cristina R Antonescu; Lei Zhang; G Petur Nielsen; Andrew E Rosenberg; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2011-06-29       Impact factor: 5.006

Review 4.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

5.  Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.

Authors:  Yu-Chien Kao; Valentina Ranucci; Lei Zhang; Yun-Shao Sung; Edward A Athanasian; David Swanson; Brendan C Dickson; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2017-11       Impact factor: 6.394

Review 6.  A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty eight cases.

Authors:  Raffaele Lombardi; Elio Jovine; Nicola Zanini; Maria Cristina Salone; Marco Gambarotti; Alberto Righi; Alba Balladelli; Marco Colangeli; Michele Rocca
Journal:  Int Orthop       Date:  2013-09-06       Impact factor: 3.075

7.  Acral myxoinflammatory fibroblastic sarcoma: A case report and literature review.

Authors:  Andrew G Silver; Richard C Baynosa; Raman C Mahabir; Wei Z Wang; William A Zamboni; Kayvan T Khiabani
Journal:  Can J Plast Surg       Date:  2013

8.  Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors.

Authors:  Jun Nishio
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

9.  A rare case of acral myxoinflammatory fibroblastic sarcoma at the hand.

Authors:  Andrea Leti Acciaro; Roberto Gabrieli; Antonio Landi
Journal:  Musculoskelet Surg       Date:  2010-01-12

10.  Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.

Authors:  David Suster; Michael Michal; Huiya Huang; Shira Ronen; Stephanie Springborn; Maria Debiec-Rychter; Steven D Billings; John R Goldblum; Brian P Rubin; Michal Michal; Saul Suster; A Craig Mackinnon
Journal:  Mod Pathol       Date:  2020-06-08       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.